{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:20:30Z","timestamp":1769746830961,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-025-00845-0","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:08:59Z","timestamp":1767492539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cross-sectional hospital-based investigation on clinical characteristics of pediatric Group A Streptococcus isolates in a Beijing hospital from 2014 to 2023"],"prefix":"10.1186","volume":"25","author":[{"given":"Luwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"11","key":"845_CR1","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3201\/eid2911.230211","volume":"29","author":"A Taylor","year":"2023","unstructured":"Taylor A, Elliott BM, Atkinson J, et al. Group A Streptococcus primary peritonitis in children, new Zealand. Emerg Infect Dis. 2023;29(11):2203\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"845_CR2","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1093\/ofid\/ofac281","volume":"9","author":"KM Miller","year":"2022","unstructured":"Miller KM, Lamagni T, Cherian T, et al. Standardization of epidemiological surveillance of invasive group A Streptococcal infections. Open Forum Infect Dis. 2022;9(Suppl 1):S31\u201340.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"845_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.00101-13","volume":"27","author":"MJ Walker","year":"2014","unstructured":"Walker MJ, Barnett TC, McArthur JD, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev. 2014;27(2):264\u2013301.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"845_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3201\/eid\/1706.100804","volume":"17","author":"A Safar","year":"2011","unstructured":"Safar A, Lennon D, Stewart J, et al. Invasive group A Streptococcal infection and vaccine implications, Auckland, new Zealand. Emerg Infect Dis. 2011;17(6):983\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"845_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A Streptococcal diseases. Lancet Infect Dis. 2005;5(11):685\u201394.","journal-title":"Lancet Infect Dis"},{"key":"845_CR6","first-page":"1","volume":"368","author":"AP Ralph","year":"2013","unstructured":"Ralph AP, Carapetis JR. Group A Streptococcal diseases and their global burden. Curr Top Microbiol Immunol. 2013;368:1\u201327.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10369","key":"845_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"GBD2019ARC","year":"2022","unstructured":"GBD2019ARC. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet (London England). 2022;400(10369):2221\u201348.","journal-title":"Lancet (London England)"},{"issue":"1","key":"845_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","volume":"321","author":"DL Stevens","year":"1989","unstructured":"Stevens DL, Tanner MH, Winship J, et al. Severe group A Streptococcal infections associated with a toxic shock-like syndrome and Scarlet fever toxin A. N Engl J Med. 1989;321(1):1\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"845_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1442-200X.1996.tb03454.x","volume":"38","author":"T Masuyama","year":"1996","unstructured":"Masuyama T, Ishii E, Muraoka K, et al. Outbreak of acute glomerulonephritis in children: observed association with the T1 subtype of group A Streptococcal infection in Northern Kyushu, Japan. Acta Paediatr Jpn. 1996;38(2):128\u201331.","journal-title":"Acta Paediatr Jpn"},{"issue":"10","key":"845_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrmicro2648","volume":"9","author":"JN Cole","year":"2011","unstructured":"Cole JN, Barnett TC, Nizet V, et al. Molecular insight into invasive group A Streptococcal disease. Nat Rev Microbiol. 2011;9(10):724\u201336.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"845_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ng.3147","volume":"47","author":"MR Davies","year":"2015","unstructured":"Davies MR, Holden MT, Coupland P, et al. Emergence of Scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance. Nat Genet. 2015;47(1):84\u20137.","journal-title":"Nat Genet"},{"issue":"11","key":"845_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1473-3099(19)30446-3","volume":"19","author":"NN Lynskey","year":"2019","unstructured":"Lynskey NN, Jauneikaite E, Li HK, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased Scarlet fever activity in england: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19(11):1209\u201318.","journal-title":"Lancet Infect Dis"},{"key":"845_CR13","unstructured":"Yu DL, Lu QH, You YH. et la. Chinese experts\u2019 consensus statement on diagnosis, treatment and prenvention of Group A Streptococcus infection related diseases in children. Chin J Appl Clin Pediatr. 2022,37(21):1604-18."},{"issue":"7","key":"845_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","volume":"21","author":"S Brouwer","year":"2023","unstructured":"Brouwer S, Rivera-Hernandez T, Curren BF, et al. Pathogenesis, epidemiology and control of group A Streptococcus infection. Nat Rev Microl. 2023;21(7):431\u201347.","journal-title":"Nat Rev Microl"},{"key":"845_CR15","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100 34th Edition."},{"key":"845_CR16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.2147\/IDR.S403304","volume":"16","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu J, Pan YC, et al. Analysis of pathogenic bacteria and drug resistance among girls with bacterial vaginitis. Infect Drug Resist. 2023;16:1849\u201363.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"845_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jpeds.2015.05.034","volume":"167","author":"HW Clegg","year":"2015","unstructured":"Clegg HW, Giftos PM, Anderson WE, et al. Clinical perineal Streptococcal infection in children: epidemiologic features, low symptomatic recurrence rate after treatment, and risk factors for recurrence. J Pediatr. 2015;167(3):687\u201393.","journal-title":"J Pediatr"},{"issue":"2","key":"845_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00431-003-1373-x","volume":"163","author":"J Cuadros","year":"2004","unstructured":"Cuadros J, Maz\u00f3n A, Martinez R, et al. The aetiology of paediatric inflammatory vulvovaginitis. Eur J Pediatr. 2004;163(2):105\u20137.","journal-title":"Eur J Pediatr"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijid.2020.11.193","volume":"103","author":"JW Cannon","year":"2021","unstructured":"Cannon JW, Zhung J, Bennett J, et al. The economic and health burdens of diseases caused by group A Streptococcus in new Zealand. Int J Infect Dis. 2021;103:176\u201381.","journal-title":"Int J Infect Dis"},{"key":"845_CR20","doi-asserted-by":"publisher","first-page":"100597","DOI":"10.1016\/j.lanepe.2023.100597","volume":"27","author":"E Cobo-V\u00e1zquez","year":"2023","unstructured":"Cobo-V\u00e1zquez E, Aguilera-Alonso D, Carrasco-Colom J, et al. Increasing incidence and severity of invasive group A Streptococcal disease in Spanish children in 2019\u20132022. Lancet Reg Health Eur. 2023;27:100597.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"845_CR21","doi-asserted-by":"publisher","first-page":"2200942","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","volume":"28","author":"R Guy","year":"2023","unstructured":"Guy R, Henderson KL, Coelho J, et al. Increase in invasive group A Streptococcal infection notifications, England, 2022. Euro Surveill. 2023;28(1):2200942.","journal-title":"Euro Surveill"},{"issue":"8","key":"845_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5694\/mja2.51909","volume":"218","author":"A MacPhail","year":"2023","unstructured":"MacPhail A, Lee WJI, Kotsanas D, et al. A rise in invasive and non-invasive group A Streptococcal disease case numbers in Melbourne in late 2022. Med J Aust. 2023;218(8):378\u20139.","journal-title":"Med J Aust"},{"issue":"5","key":"845_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3201\/eid2805.211497","volume":"28","author":"LE Nabarro","year":"2022","unstructured":"Nabarro LE, Brown CS, Balasegaram S, et al. Invasive group A Streptococcus outbreaks associated with home healthcare, England, 2018\u20132019. Emerg Infect Dis. 2022;28(5):915\u201323.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"845_CR24","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/S2589-7500(24)00241-3","volume":"7","author":"D Shaw","year":"2025","unstructured":"Shaw D, Torreblanca RA, Amin-Chowdhury Z, et al. The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance. Lancet Digit Health. 2025;7(4):e275\u201381.","journal-title":"Lancet Digit Health"},{"issue":"1","key":"845_CR25","doi-asserted-by":"publisher","first-page":"e0009070","DOI":"10.1371\/journal.pntd.0009070","volume":"15","author":"A Tariq","year":"2021","unstructured":"Tariq A, Undurraga EA, Laborde CC, et al. Transmission dynamics and control of COVID-19 in Chile, March-October, 2020. PLoS Negl Trop Dis. 2021;15(1):e0009070.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"845_CR26","doi-asserted-by":"publisher","first-page":"e00716","DOI":"10.1128\/mSphere.00716-20","volume":"5","author":"CPF Domingues","year":"2020","unstructured":"Domingues CPF, Rebelo JS, Dionisio F, et al. The social distancing imposed to contain COVID-19 can affect our microbiome: a double-edged sword in human health. mSphere. 2020;5(5):e00716\u201320.","journal-title":"mSphere"},{"issue":"4 Pt 1","key":"845_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1542\/peds.105.4.738","volume":"105","author":"L Roberts","year":"2000","unstructured":"Roberts L, Smith W, Jorm L, et al. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics. 2000;105(4 Pt 1):738\u201342.","journal-title":"Pediatrics"},{"issue":"1","key":"845_CR28","first-page":"Cd006207","volume":"1","author":"T Jefferson","year":"2023","unstructured":"Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2023;1(1):Cd006207.","journal-title":"Cochrane Database Syst Rev"},{"key":"845_CR29","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.2147\/IDR.S486832","volume":"17","author":"L Wang","year":"2024","unstructured":"Wang L, Zhen JH, Dong F, et al. Cross-sectional hospital-based investigation on clinical characteristics of pediatric Staphylococcus aureus isolates in a Beijing hospital from 2013 to 2022. Infect Drug Resist. 2024;17:4899\u2013912.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"845_CR30","first-page":"256","volume":"86","author":"Y Li","year":"2023","unstructured":"Li Y, Cao Y, Ding X, et al. Influence of the COVID-19 pandemic on Staphylococcus aureus bloodstream infection in children, Henan, China. J Infect. 2023;86(3):256\u2013308.","journal-title":"J Infect"},{"issue":"2","key":"845_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00431-022-04718-y","volume":"182","author":"NP Boeddha","year":"2023","unstructured":"Boeddha NP, Atkins L, de Groot R, et al. Group A Streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr. 2023;182(2):697\u2013706.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"845_CR32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/S1473-3099(21)00699-X","volume":"21","author":"D Yu","year":"2021","unstructured":"Yu D, Liang Y, Zheng Y, et al. Clindamycin-resistant Streptococcus pyogenes in Chinese children. Lancet Infect Dis. 2021;21(12):1631\u20132.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"845_CR33","doi-asserted-by":"publisher","first-page":"e1266","DOI":"10.1093\/cid\/ciac468","volume":"76","author":"Y Li","year":"2023","unstructured":"Li Y, Rivers J, Mathis S, et al. Continued increase of erythromycin nonsusceptibility and clindamycin nonsusceptibility among invasive group A Streptococci driven by genomic clusters, united States, 2018\u20132019. Clin Infect Dis. 2023;76(3):e1266\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"845_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/cid\/ciaa027","volume":"72","author":"T Bruun","year":"2021","unstructured":"Bruun T, Rath E, Madsen MB, et al. Risk factors and predictors of mortality in Streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clin Infect Dis. 2021;72(2):293\u2013300.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"845_CR35","doi-asserted-by":"publisher","first-page":"e0072923","DOI":"10.1128\/msphere.00729-23","volume":"9","author":"E Ram\u00edrez de Arellano","year":"2024","unstructured":"Ram\u00edrez de Arellano E, Saavedra-Lozano J, Villal\u00f3n P, et al. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak. mSphere. 2024;9(3):e0072923.","journal-title":"mSphere"},{"issue":"2","key":"845_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmii.2013.08.015","volume":"48","author":"PK Chuang","year":"2015","unstructured":"Chuang PK, Wang SM, Lin HC, et al. The trend of macrolide resistance and Emm types of group A Streptococci from children at a medical center in Southern Taiwan. J Microbiol Immunol Infect. 2015;48(2):160\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"845_CR37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-2958.1996.01521.x","volume":"22","author":"J Clancy","year":"1996","unstructured":"Clancy J, Petitpas J, Dib-Hajj F, et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol. 1996;22(5):867\u201379.","journal-title":"Mol Microbiol"},{"issue":"52","key":"845_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.46234\/ccdcw2023.217","volume":"5","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ding L, Yang Y, et al. Multicenter antimicrobial resistance surveillance of clinical isolates from major hospitals-China, 2022. China CDC Wkly. 2023;5(52):1155\u201360.","journal-title":"China CDC Wkly"},{"key":"845_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3389\/fmicb.2018.00542","volume":"9","author":"Y Shen","year":"2018","unstructured":"Shen Y, Cai J, Davies MR, et al. Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring Tetracycline and macrolide resistance in Shanghai, China. Front Microbiol. 2018;9:542.","journal-title":"Front Microbiol"},{"issue":"3","key":"845_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jiac.2019.10.004","volume":"26","author":"K Tatara","year":"2020","unstructured":"Tatara K, Gotoh K, Okumiya K, et al. Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan. J Infect Chemother. 2020;26(3):280\u20134.","journal-title":"J Infect Chemother"},{"issue":"3","key":"845_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1099\/jmm.0.001158","volume":"69","author":"K Ubukata","year":"2020","unstructured":"Ubukata K, Wajima T, Morozumi M, et al. Changes in epidemiologic characteristics and antimicrobial resistance of Streptococcus pyogenes isolated over 10 years from Japanese children with pharyngotonsillitis. J Med Microbiol. 2020;69(3):443\u201350.","journal-title":"J Med Microbiol"},{"issue":"5","key":"845_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0022-3476(05)80840-6","volume":"123","author":"M Markowitz","year":"1993","unstructured":"Markowitz M, Gerber MA, Kaplan EL. Treatment of Streptococcal pharyngotonsillitis: reports of penicillin\u2019s demise are premature. J Pediatr. 1993;123(5):679\u201385.","journal-title":"J Pediatr"},{"issue":"5","key":"845_CR43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.4269\/ajtmh.18-0907","volume":"100","author":"JL de Dassel","year":"2019","unstructured":"de Dassel JL, Malik H, Ralph AP, et al. Four-weekly benzathine penicillin g provides inadequate protection against acute rheumatic fever in some children. Am J Trop Med Hyg. 2019;100(5):1118\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"845_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cid\/ciz1000","volume":"71","author":"KS Vannice","year":"2020","unstructured":"Vannice KS, Ricaldi J, Nanduri S, et al. Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to \u03b2-lactam antibiotics. Clin Infect Dis. 2020;71(1):201\u20134.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"845_CR45","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/membranes11110806","volume":"11","author":"M Bielaszewska","year":"2021","unstructured":"Bielaszewska M, Daniel O, Ny\u010d O, et al. In vivo secretion of \u03b2-lactamase-carrying outer membrane vesicles as a mechanism of \u03b2-lactam therapy failure. Membranes. 2021;11(11):806.","journal-title":"Membranes"},{"key":"845_CR46","doi-asserted-by":"publisher","first-page":"716628","DOI":"10.3389\/fmicb.2021.716628","volume":"12","author":"CL Martini","year":"2021","unstructured":"Martini CL, Coronado AZ, Melo MCN, et al. Cellular growth arrest and efflux pumps are associated with antibiotic persisters in Streptococcus pyogenes induced in biofilm-like environments. Front Microbiol. 2021;12:716628.","journal-title":"Front Microbiol"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00845-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00845-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00845-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:03:26Z","timestamp":1769699006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12941-025-00845-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00845-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The GAS isolates analyzed in this study were collected from clinical laboratories. Our study was a retrospective study based on the clinical specimens, which were part of the routine hospital laboratory procedures. This study was reviewed and approved by the Ethics Committee of Beijing Children\u2019s Hospital. The ethics committee waived the need for participants\u2019 informed consent because the study was retrospective. The study was conducted following the principle of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}